Yes / Capsella bursa-pastoris (L.) Medik. is a species with a cosmopolitan distribution which shows considerable morphological variation. Numerous authors have recognised widely differing numbers of varieties, microspecies or other infraspecific subdivisions (segregates) of this species. In an attempt to clarify this situation, we grew British material of the species under controlled conditions through to the F) generation to remove environmental variation, and assessed the plants on the basis of a range of morphological criteria, namely leaf shape, capsule size and also length of time taken to flower. Analysis of these characteristics consistently produced four basic groups, which had been previously described. Herbarium specimens could also nearly always be assigned to one of these groups. Limited chromosome counts suggest that two of these groups are diploid and two are tetraploid. We suggest this fourfold division into broad groups reflects the major genetic separations within the species, but that there is also considerable phenotypic plasticity shown by C. bursapastoris in response to factors such as shade or trampling. These four groups appear to differ in their geographic.al distribution in Britain. KEYWORDS: Shepherd's Purse, morphological variation, leaf characters, capsule characters, chromosome

No

Les lipoprotéines de haute densité (High Density Lipoprotein, HDL) permet deréduction de risque de maladies cardio-vasculaires principalement en raison de leurcapacité à éliminer le cholestérol accumulé des artères (via transport inverse ducholestérol). Les effets protecteurs des HDL sont médiés par l'apolipoprotéine AI(ApoA1), qui est le La protéine la plus importante quantitativement du HDL. L’ApoA1favorise l'efflux de cholestérol vers le foie pour l'excrétion. Une augmentation desniveaux plasmatiques de l’ApoA1 est généralement acceptée d'êtrecardioprotecteur, ce qui en fait un potentiel thérapeutique. Deux variantes naturelle(mutants) de l’ApoA1, Milano et Paris, sont caractérisées par une mutationponctuelle unique a permis l'introduction d'un résidu cystéine. Populations avecApoA1-Milano ont été rapportés d'avoir un système cardiovasculaire, même avec defaibles niveaux de plasma de ApoA1 et HDL. Il est donc d'intérêt pour générerrecombinante de type sauvage et des variantes de ApoA1 humaine pour desapplications thérapeutiques potentielles. Dans cette étude, de type sauvagerhApoA1 a été produit chez P. pastoris et purifié par chromatographie en modemixte en une seule étape. Par la suite, un processus intégré a été le développementde la production et la récupération rapide de type sauvage rhApoA1 chez P. pastorispar chromatographie par lit expansée. En outre, les variantes de l'ApoA1, Milano &Paris, ont été générées par mutagenèse dirigée et ont été exprimés chez P. pastoris.Les motifs d’adsorption de rhApoA1-Milano et rhApoA1-Paris ont été comparés àcelle de type sauvage ApoA1 et les différences ont été discutées. / The high-density lipoprotein (HDL) complex helps reduce the risk of cardiovasculardisorders mainly due to its ability to remove accumulated cholesterol from arteriesvia reverse cholesterol transport. These protective effects of HDL are known to bemediated by Apolipoprotein A-I (ApoA1), which is the major protein component ofHDL. ApoA1 is a lipid binding protein and promotes cholesterol efflux fromperipheral tissues to the liver for excretion. An increase in the plasma levels ofApoA1 is generally accepted to be cardioprotective, making it a potentialtherapeutic. Two naturally occuring variants of ApoA1, namely the Milano & Parismutants, are characterised by a single point mutation resulting in the introduction ofa Cysteine residue. Populations with ApoA1-Milano have been reported to have ahealthier cardiovascular system even with low plasma levels of ApoA1/HDL. It ishence of interest to generate recombinant wild type and variants of human ApoA1for potential therapeutic applications. In this study, wild type rhApoA1 was producedin P. pastoris and purified by mixed-mode chromatgraphy in a single step.Subsequently, an integrated process has been development for the production andrapid recovery of wild type rhApoA1 in Pichia pastoris. This has paved way to theestablishment of a scalable integrated process that could be further developed toindustrial levels. In addition, the cysteine variants of ApoA1, Milano & Paris, havebeen generated by site directed mutagenesis and have been successfully expressedin P. pastoris. The binding patterns of rhApoA1-Milano and rhApoA1-Paris have beencompared with that of wild-type ApoA1 and the differences have been discussed.

LOPAP, proteína isolada da toxina de lagartas Lonomia obliqua, possui ação ativadora de protrombina, efeito pró-coagulante e ação citoprotetora em células do endotélio humano, em cultura. Tem cadeia única com 181 resíduos de aminoácidos e 21 kDa. Sua estrutura terciária é formada por oito folhas-b fechadas em uma extremidade, mantidas juntas por pontes de hidrogênio, em formato de barril. Está classificada como pertencente ao grupo das Lipocalinas (proteínas de transporte). Neste trabalho estudou-se o LOPAP, que foi produzido recombinante em cultivo de Pichia pastoris em biorreator e purificado. Avaliou-se sua estabilidade quanto às atividades enzimática e citoprotetora, e sua estrutura secundária. Não foi detectada ativação de protrombina para o r-LOPAP obtido, mas foi observada ação citoprotetora. Considerando estes resultados e a análise de sua estrutura secundária por dicroísmo circular, concluiu-se que a proteína foi expressa com tamanho e sequência corretos, mas sem uma estrutura terciária correta, o que é determinante para a atividade enzimática. / LOPAP, a protein isolated from the toxin of Lonomia obliqua caterpillars, has prothrombin activation action, procoagulant effect and cytoprotection action in human endothelium cells culture. It has only chain with 181 amino acid residues and 21 kDa of size. Its tertiary structure is made by eight b-sheets closed at one end, hold together by hydrogen bonds, barrel-shaped. It is classified as belonging to the Lipocalin group (proteins of transport). This work studied the LOPAP, which was produced recombinant in Pichia pastoris culture in bioreactor, was purified, and it was evaluated its stability related to enzymatic and cytoprotection activities, and its secondary structure. It was not detected prothrombin activation for the r-LOPAP obtained, but it was observed a cytoprotective effect. Regarding these results and the analysis of its secondary structure, by circular dichroism, it was concluded that the protein was expressed with correct size and sequence, but without a correct tertiary structure, which is determinant for the enzymatic activity.

Made available in DSpace on 2016-06-02T19:56:40Z (GMT). No. of bitstreams: 1 3187.pdf: 3659896 bytes, checksum: 975ac91a3eb67a4347c326de8f22bf8e (MD5) Previous issue date: 2010-03-31 / Universidade Federal de Minas Gerais / This master's thesis project aims at studying the dynamic optimization of the operation of a bench scale (up to 5L) automated, agitated and aerated bioreactor, where the semi-continuous cultivation of recombinant Pichia pastoris is run. This yeast was cloned using the PGK1 promoter, which precludes the use of methanol as inducer, expressing constitutively the enzyme penicillin G Acylase (PGA) from Bacillus megaterium. While the group of molecular biology of DEQUFSCar is working on cloning the PGA, d P. pastoris expressing the enzyme - amylase from Bacillus subtilis was cultivated. This clone, provided by prof. Fernando Torres, UnB, uses the same construction and, therefore, its kinetics of growth and production should be very similar to the PGA s. Cultivation of recombinant Pichia pastoris was performed in flasks (skaker) using standard culture medium, aiming at obtaining kinetic data, which are the starting point for the escalation to a benchtop bioreactor. Following that, tests were performed in a 5L bioreactor in batch and fed batch operation modes. With the bioreactor data , kinetic parameters of growth, to be further used in the simulations, were estimated, using a hybrid algorithm (which combines the global method Simulated Annealing, with the local one Levenberg- Marquardt). This algorithm, is implemented in Matlab and available in the software library of Ladabio (Laboratory of Development and Automation of Bioprocesses ). From these data, models of microbial growth and of production were developed, following a classic approach (unstructured, non-segregated). Computer simulations using different feeding strategies and employing these models allowed mapping the dynamics of the system. From this information, optimal control strategies were proposed to define optimal feeding profiles. Cellular concentrations of 5.4 g/L (dry weight) were reached in shaker (20h of cultivation, when glucose is exhausted), expressing 218 U/mL of -amylase, compared to 11.4 g/L (dry weight) that were achieved in cultures in a bioreactor in batch simple (10h of cultivation, when glucose is exhausted), expressing 156 U/mL of -amylase In fed-batch cultures, cell concentrations of up to 45 g/L were achieved, expressing up to 260 U/mL of - amylase, with a productivity of 5.2 U/mL/ h. In fed-batch cultures of P. pastoris expressing PGA, cell concentrations of up to 35 g/L were achieved. Enzyme activity was not detected in the culture broth due to the effect of glycosylation. Immunodetection reaction confirmed the expression of the recombinant enzyme. Four specific growth rate equations were adjusted, with different types of inhibition by one product, detected at significant levels by liquid chromatography highperformance, but not yet identified. This metabolite was added as an inhibitor in kinetic models, using the peak areas, normalized as a pseudoconcentration. The best fit to the experimental data were the Monod kinetic model with non-competitive inhibition. Typical values obtained for the maximum specific growth and glucose/ cell conversion factor in bioreactor were max=0,24 h-1 and YX/S = 0,48. Algorithm for optimal control in open loop was developed and successfully implemented, providing a robust profiles of great power, whose validation is proposed as a continuation of this work. / Este mestrado se propoe a estudar a otimizacao dinamica de biorreator automatizado, tipo tanque agitado e aerado, em escala de bancada (ate 5L), onde se processa o cultivo semi-continuo de Pichia pastoris recombinante. Essa levedura foi clonada pelo grupo do prof. Fernando Torres, da UnB, utilizando o promotor PGK1, que dispensa a utilizacao de metanol como indutor, expressando constitutivamente a enzima -amilase de Bacillus subtilis. Durante a execucao deste mestrado, a enzima penicilina G acilase (PGA) de Bacillus megaterium esta sendo clonada pelo grupo de biologia molecular do DEQ-UFSCar usando a mesma construcao e, portanto, a cinetica de crescimento e producao da PGA heterologa devera ser muito semelhante as da -amilase, utilizada como estudo de caso para otimizacao do bioprocesso. Cultivos de Pichia pastoris recombinante foram realizados em frascos agitados, utilizando meio de cultivo padrao, objetivando o levantamento de dados cineticos, ponto de partida para o escalonamento em biorreator de bancada. Posteriormente, foram realizados ensaios em biorreator de 5L, em batelada e batelada alimentada. Com os dados obtidos nos cultivos em biorreator, e utilizando algoritmo hibrido para estimativa de parametros (que combina o metodo global Simulated Annealing, com o local de Levenberg-Marquardt), implementado em MatLab e disponivel no LaDABio (Laboratorio de Desenvolvimento e Automacao de Bioprocessos), foram ajustados parametros cineticos de crescimento, para serem utilizados nas simulacoes dos cultivos em biorreator. A partir dai, foi desenvolvido modelo de crescimento microbiano e de producao, utilizando um enfoque classico (modelo nao-estruturado, nao-segregado) para descrever o sistema. Com isso, torna-se possivel realizar simulacoes em computador usando diferentes estrategias de alimentacao, para mapear a dinamica do sistema. A seguir, foram desenvolvidos algoritmos de controle otimo em malha aberta para definicao de estrategias de alimentacao. Concentracoes celulares de 5,4 g/L (massa seca) foram alcancadas em cultivos em camara rotatoria (20h de cultivo, quando se esgota a glicose), expressando 218 U/mL de -amilase, comparado com 11,4 g/L(massa seca) que foram atingidos em cultivos em biorreator em bateladas simples (10h de cultivo, quando se esgota a glicose), expressando 156 U/mL de -amilase. Em cultivos em batelada alimentada concentracoes celulares de ate 45 g/L foram atingidas, expressando ate 260 U/mL de -amilase, com uma produtividade de 5,2 U/mL/h. Em cultivo em batelada alimentada de P. pastoris expressando PGA, concentracoes celulares de ate 35 g/L foram atingidas. Nao foi detectada atividade enzimatica no caldo de cultivo devido ao efeito da glicosilacao. Reacao de imunodeteccao confirmou a expressao da enzima recombinante. Foram ajustadas quatro equacoes de velocidade especifica de crescimento, com diferentes tipos de inibicao por um produto, detectado em niveis importantes por cromatografia liquida de alto desempenho, mas ainda nao identificado. Esse metabolito foi inserido como inibidor nos modelos cineticos, utilizando as areas dos picos, normalizadas, como uma pseudoconcentracao. Os melhores ajustes aos dados experimentais foram com modelo cinetico de Monod com inibicao nao-competitiva. Valores tipicos obtidos para a velocidade especifica maxima de crescimento e de fator de conversao glicose/celula em biorreator foram max = 0,24 h-1 e YX/S = 0,48. Algoritmo de controle otimo em malha aberta foi desenvolvido e implementado com sucesso, prevendo de forma robusta perfis otimos de alimentacao, cuja validacao fica proposta como continuidade deste trabalho.

LOPAP, proteína isolada da toxina de lagartas Lonomia obliqua, possui ação ativadora de protrombina, efeito pró-coagulante e ação citoprotetora em células do endotélio humano, em cultura. Tem cadeia única com 181 resíduos de aminoácidos e 21 kDa. Sua estrutura terciária é formada por oito folhas-b fechadas em uma extremidade, mantidas juntas por pontes de hidrogênio, em formato de barril. Está classificada como pertencente ao grupo das Lipocalinas (proteínas de transporte). Neste trabalho estudou-se o LOPAP, que foi produzido recombinante em cultivo de Pichia pastoris em biorreator e purificado. Avaliou-se sua estabilidade quanto às atividades enzimática e citoprotetora, e sua estrutura secundária. Não foi detectada ativação de protrombina para o r-LOPAP obtido, mas foi observada ação citoprotetora. Considerando estes resultados e a análise de sua estrutura secundária por dicroísmo circular, concluiu-se que a proteína foi expressa com tamanho e sequência corretos, mas sem uma estrutura terciária correta, o que é determinante para a atividade enzimática. / LOPAP, a protein isolated from the toxin of Lonomia obliqua caterpillars, has prothrombin activation action, procoagulant effect and cytoprotection action in human endothelium cells culture. It has only chain with 181 amino acid residues and 21 kDa of size. Its tertiary structure is made by eight b-sheets closed at one end, hold together by hydrogen bonds, barrel-shaped. It is classified as belonging to the Lipocalin group (proteins of transport). This work studied the LOPAP, which was produced recombinant in Pichia pastoris culture in bioreactor, was purified, and it was evaluated its stability related to enzymatic and cytoprotection activities, and its secondary structure. It was not detected prothrombin activation for the r-LOPAP obtained, but it was observed a cytoprotective effect. Regarding these results and the analysis of its secondary structure, by circular dichroism, it was concluded that the protein was expressed with correct size and sequence, but without a correct tertiary structure, which is determinant for the enzymatic activity.

Made available in DSpace on 2014-08-20T14:37:49Z (GMT). No. of bitstreams: 1 dissertacao_paula_finger.pdf: 729110 bytes, checksum: fe15bb22f0abb92bf1b2938fd6dcdfc9 (MD5) Previous issue date: 2011-12-19 / The chickens infectious bronchitis (IB) is a highly contagious viral disease which causes predominantly respiratory lesions manifested clinically and invariably by sneezing and tracheo-bronchial rales, which may lead to more severe signs, with a decrease in fertility and reduction of eggs production. The infectious bronchitis virus (IBV) encodes four major structural proteins: N (nucleocapsid protein), S (spike protein), E (envelope protein) and M (membrane protein) being the S protein is cleaved into S1 and S2. The 1 subunit (S1) is found exposed in the viral envelope, which makes it an important or main inducer of neutralizing antibodies against the IBV, the main target for the host s immune system. The variations in two regions of the envelope s S1 subunit, called hypervariables regions, may originate to new serotypes. The IBV s mutation and recombination capacity and the selection pressure exerted by the prolonged use of live vaccines contribute to the appearance of a wide variety of serotypes and subtypes of IBV. The objective of this study was to express, in Pichia pastoris, the gene that encodes the surface protein S1 of IBV strain M41 and, in Escherichia coli, to express the S1 of the synthetic gene designed from consensus sequences of national and international field samples, as an interesting alternative for the production of antigen that can be used for monitoring vaccination of birds and also an antigen that is suitable for the use in serological diagnostic. The cloning and expression of glycoprotein S1 in both heterologous expression systems was successfully performed. The process of expression using E. coli was simple and quick when compared to the use of P. pastoris. The P. pastoris was able to express the entire S1; however, it showed difficulty in secreting the glycoprotein. The results will be evaluated for use in immunodiagnostic kit for monitoring the disease in poultry, being more affordable than the ones existing currently. / A bronquite infecciosa das galinhas (IB) é uma enfermidade viral altamente contagiosa que causa predominantemente lesões respiratórias que se manifestam clinicamente e invariavelmente por espirros e estertores tráqueo-bronquiolares, podendo levar a sinais mais severos, com diminuição na fertilidade e redução da produção de ovos. O vírus da bronquite infecciosa das galinhas (IBV) codifica quatro proteínas estruturais importantes: N (proteína do nucleocapsídeo), S (proteína de superfície), E (proteína do envelope) e M (proteína da membrana), sendo a proteína S subdividida em S1 e S2. A subunidade 1 (S1) encontra-se exposta no envelope viral, o que torna-a um importante, ou principal, indutor da produção de anticorpos neutralizantes frente ao IBV, sendo o principal alvo para o sistema imune do hospedeiro. As variações em duas regiões da subunidade S1 do envelope, chamadas regiões hipervariáveis, podem dar origem a novos sorotipos. A capacidade de mutação e recombinação de IBV e a pressão de seleção exercida pelo uso prolongado de vacinas vivas contribuem para o aparecimento de uma grande variedade de sorotipos e subtipos de IBV. O objetivo deste trabalho foi expressar em Pichia pastoris o gene que codifica a proteína de superfície S1 da estirpe M41 do IBV e, em Escherichia coli, expressar a S1 de um gene sintético elaborado a partir de sequências consenso de amostras de campo nacionais e internacionais, como uma alternativa interessante para a produção de antígeno que possa ser utilizado para monitoramento vacinal das aves e também um antígeno que seja adequado para utilização em diagnóstico sorológico. A clonagem e a expressão da glicoproteína S1 em ambos os sistemas heterólogos de expressão foi realizada com sucesso. O processo de expressão usando E. coli foi rápido e simples quando comparado ao uso da P. pastoris. A P. pastoris foi capaz de expressar a S1 inteira, porém, apresentou dificuldade em secretar a glicoproteína. Os resultados obtidos deverão ser avaliados para uso em Kit de imunodiagnóstico para monitoramento da enfermidade na avicultura, sendo de custo mais acessível do que os existentes no mercado.

Benzaldehyde (BZA), a biologically derived high-value molecule used in the flavour and fragrance industry for its characteristic almond-like aroma, has also found use in nutraceutical, pharmaceutical, cosmetics, agrochemical, and dye applications. Although, nature-identical BZA is most commonly produced by chemical synthesis, biologically derived BZA, whether by plant material extraction or via microbial biocatalysts, commands much higher prices. The bioproduction of high value molecules has often been characterized by low titers as results of substrate and product inhibition. The current work examined a variety of process strategies and the implementation of a solid-liquid bioreactor partitioning system with continuous integrated pervaporation to enhance the bioproduction of BZA using Pichia pastoris. Previous work on two-phase partitioning bioreactors (TPPBs) for the biotransformation of BZA using Pichia pastoris has had limitations due to long fermentation times and unutilized substrate in the immiscible polymer phase, contributing to complications for product purification. To reduce fermentation times, a mixed methanol/glycerol feeding strategy was employed and reduced the time required for high-density fermentation by 3.5 fold over previous studies. Additionally, because BZA and not the substrate benzyl alcohol (BA) had been found to be significantly inhibitory to the biotransformation reaction, a polymer selection strategy based on the ratio of partition coefficients (PCs) for the two target molecules was implemented. Using the polymer Kraton D1102K, with a PC ratio of 14.9 (BZA:BA), generated a 3.4 fold increase in BZA produced (14.4 g vs. 4.2 g) relative to single phase operation at more than double the volumetric productivity (97 mg L-1 h-1 vs. 41 mg L-1 h-1). This work also confirmed that the solute(s) of interest were taken up by polymers via absorption, not adsorption. BZA and BA cell growth inhibition experiments showed that these compounds are toxic to cells and it was their accumulation rather than low enzyme levels or energy (ATP) depletion that caused a reduction in the biotransformation rate. For this reason, the final strategy employed to enhance the bioproduction of benzaldehyde involved in situ product removal by pervaporation using polymer (Hytrel 3078) fabricated into tubing by DuPont, Canada. This aspect was initiated by first characterizing the custom-fabricated tubing in terms BZA and BA fluxes. The tubing was then integrated into an in situ pervaporation biotransformation and was shown to be effective at continuous product separation, using 87.4% less polymer by mass in comparison to polymer beads in conventional TPPB operation, and improved overall volumetric productivity by 214% (245.9 mg L-1 h-1 vs. 115.0 mg L-1 h-1) over previous work producing BZA. / Thesis (Master, Chemical Engineering) -- Queen's University, 2013-09-28 17:41:45.458

La chymosine, enzyme utilisée dans l´industrie fromagère pour coaguler le lait, est traditionnellement extraite à partir du quatrième estomac de veaux non sevrés. La préparation ainsi obtenue dénommée présure a été depuis un certain nombre d´années substituée par divers coagulants d´origine microbienne et de plantes car la production de cette enzyme seule n´était plus capable de répondre à la demande mondiale du fait notamment de l´augmentation de la production fromagère. La chymosine est cependant toujours considérée comme étant la meilleure enzyme pour coaguler le lait dans l´industrie fromagère. Ainsi, les techniques d´ingénierie génétique ont été utilisées pour produire de la chymosine bovine recombinante. C´est en utilisant ces techniques que nous proposons d´établir un procédé de production de chymosine bovine recombinante permettant l'innovation technologique et contribuant au maintien et au développement d'entreprises agro-alimentaires brésiliennes et des pays du Marché Economique du « Cone Sul » (MercoSul).<br />Nous avons ainsi cloné les séquences codant la préprochymosine A et la préprochymosine B à l'aide des techniques classiques de biologie moléculaire. Nous avons observé la présence de mutations dans la partie du propeptide de la prochymosine A et dans la partie mature de la prochymosine B. Cette dernière mutation, S79N, se situe dans la partie du tampon (résidus 72 à 86) qui constitue une anse externe mobile recouvrant le sillon du site actif. La conformation de ce tampon est caractéristique de la chymosine et serait en partie responsable pour sa grande spécificité. Nous avons modélisé cette mutation, qui semble entraîner des changements dans le réseau de liaisons hydrogène du tampon. Les séquences obtenues ont ainsi été introduites dans différents vecteurs d´expression puis clonées chez Escherichia coli et Pichia pastoris. L'expression des protéines a été suivie à l'aide d'anticorps spécifiques et au moyen de tests d'activité. Les différentes protéines sont toutes actives et ont été purifiées à l'homogénéité. Nous avons alors étudié leurs propriétés cinétiques à l'aide de différents substrats. Les chymosines B et BS79N ont un optimum de pH qui les différencie de la chymosine A. Le mutant B S79N a des propriétés cinétiques améliorées avec l´hexapeptide synthétique. La mutation S79N n´entraîne toutefois qu´une petite augmentation de la constante d´efficacité concernant les hydrolyses de la caséine Κ et du lait, bien que ses vitesses de réactions catalytiques soient supérieures à celles de la chymosine B. Ces résultats sont expliqués par les modifications dans le réseau de liaisons hydrogène du tampon, et par le fait que le nombre d'interactions entre le substrat et l'enzyme est une fonction de la masse moléculaire et de la nature du substrat.

In this study, it was aimed to develop a bioprocess using the Pichia pastoris expression system as an alternative to the mammalian system used in industry, for production of the therapeutically important glycoprotein, erythropoietin, and to form stoichiometric and kinetic models. Firstly, the human EPO gene, fused with a polyhistidine-tag and factor-Xa protease target site, in which cleavage produces the native termini of EPO, was integrated to AOX1 locus of P. pastoris. The Mut+ strain having the highest rHuEPO production capacity was selected. The glycosylation profile of rHuEPO was characterized by MALDI-ToF MS and Western blotting. The native polypeptide form of human EPO was obtained for the first time in P. pastoris expression system, after affinity-purification, deglycosylation and factor-Xa protease digestion. Thereafter, effects of medium components and pH on rHuEPO production and cell growth were investigated in laboratory-scale bioreactors. Sorbitol was shown to increase production efficiency when added as a co-substrate. Moreover, a cheap alternative nutrient, the byproduct of biodiesel industry, crude-glycerol, was suggested for the first time for P. pastoris fermentations. Furthermore, methanol feeding strategy was investigated in fed-batch pilot-scale bioreactors, producing 70 g L-1 biomass and 130 mg L-1 rHuEPO at t=24h. Moreover, metabolic flux analysis by using the stoichiometric model formed, which consisted of m=102 metabolites and n=141 reactions, proved useful in further understanding the P. pastoris metabolism. Finally, the first structured kinetic model formed for r-protein production with P. pastoris successfully predicted cell growth, substrate consumption and r-product production rates, where rHuEPO production kinetics was associated with AOX production and proteolytic degradation.